StockData
BioAtla, Inc. logo

BioAtla, Inc. (BCAB) stock

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

BioAtla price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BioAtla's price to sales ratio was 406.8× on Jul 29, 2022.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 2022406.8×–

More BioAtla figures

See a number that looks wrong?